Notice: This company has been marked as potentially delisted and may not be actively trading. Apricus Biosciences (APRI) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Enlyte Launches Apricus Physical Medicine, Offering End-to-End Specialty Service Solution for IndustryOctober 10, 2024 | tmcnet.comApricus Generation Acquires Solar and Storage Developer Nexus RenewablesMay 29, 2024 | tmcnet.comLundquist Institute Start-Up Vitalex Biosciences Awarded Grant from NIAID/NIHMay 16, 2023 | finance.yahoo.comErectile Dysfunction Market Analysis and Growth Foresights till 2031May 16, 2023 | marketwatch.comErectile Dysfunction Drugs Market Market Projection and Growth Drivers 2023-2028April 29, 2023 | marketwatch.comErectile Dysfunction Drugs Market 2023-2028 Recent Study by Trend and Growth AnalysisMarch 11, 2023 | marketwatch.comErectile Dysfunction Medicine Market : Key Player, Competition Weakness and Strengths from 2023 to 2028January 10, 2023 | marketwatch.comErectile Dysfunction Market Market Size 2023 Industry Analysis, Key Players, Regional Demand, Opportunity and Forecast 2028December 18, 2022 | marketwatch.comErectile Dysfunction Market Size From 2022 To 2029 And Unlimited Opportunities for New Companies and Latest DevelopmentsOctober 15, 2022 | marketwatch.comDiurnal Group - Proposed acquisition by Neurocrine BiosciencesSeptember 30, 2022 | finanznachrichten.deGreat Psychedelics And Business Events Are Coming In Q4: Check Them Out HereSeptember 13, 2022 | markets.businessinsider.comSeelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics ConferenceSeptember 9, 2022 | markets.businessinsider.comSeelos Receives R&D Grant From Michael J. Fox Foundation For Parkinson's Research For SLS-004August 24, 2022 | markets.businessinsider.comAt 5.6% CAGR, Erectile Dysfunction Market Size Set to Register 7328.5 million USD by 2028August 16, 2022 | marketwatch.comErectile Dysfunction Treatment Drugs Market 2022, Worth USD 7328.5 Mn by 2028 at CAGR of 5.6% – Report Spread across 85 PagesAugust 6, 2022 | marketwatch.comAytu BioPharma, Inc.: Aytu BioPharma Announces the Appointment of Vivian Liu to the Company's Board of DirectorsJune 29, 2022 | finanznachrichten.deAytu BioPharma Announces the Appointment of Vivian Liu to the Company’s Board of DirectorsJune 29, 2022 | apnews.comErectile Dysfunction Drugs Market Grow at a CAGR of 5.0% During 2017- 2027March 12, 2022 | benzinga.comInvesting in Psychedelic StocksDecember 20, 2021 | fool.comSeelos Therapeutics to Participate in the 11th Annual LifeSci Partners Corporate Access EventDecember 16, 2021 | markets.businessinsider.comSeelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual KetamineNovember 24, 2021 | markets.businessinsider.comSeelos Therapeutics to Present at the 4th Annual ALS ONE Research SymposiumNovember 10, 2021 | markets.businessinsider.comApricus Biosciences to Present at the 2016 BIO Investor ForumOctober 26, 2021 | finance.yahoo.comSeelos Therapeutics to Present a Poster on SLS-002 (Intranasal Racemic Ketamine) at the 2021 IASR/AFSP International Summit on Suicide ResearchOctober 1, 2021 | markets.businessinsider.comWhy This Seelos Therapeutics Analyst Is Turning Bullish On Potential Trial ResultsSeptember 27, 2021 | markets.businessinsider.comSeelos Therapeutics to Participate in Two Investor Conferences in SeptemberSeptember 9, 2021 | markets.businessinsider.comSeelos Therapeutics Announces Senior Management AppointmentsSeptember 1, 2021 | markets.businessinsider.comSeelos Therapeutics Promotes Michael Golembiewski To CFO - Quick FactsSeptember 1, 2021 | markets.businessinsider.com Get Apricus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Top "Sleeping Giant" Crypto In The Market Now (Ad)Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late APRI Media Mentions By Week APRI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APRI News Sentiment▼0.000.54▲Average Medical News Sentiment APRI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APRI Articles This Week▼00▲APRI Articles Average Week Get Apricus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CTMX News Today ASRT News Today SLS News Today EPRX News Today AVTE News Today MNOV News Today CRVO News Today BYSI News Today SPRO News Today ALXO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APRI) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apricus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apricus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
